Global radiopharmaceuticals in nuclear medicine market is estimated to be valued at USD 7.72 Bn in 2025 and is expected to reach USD 13.85 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 8.7% from 2025 to 2032. https://hallbook.com.br/blogs/759491/Radiopharmaceuticals-in-Nuclear-Medicine-Market-Driving-Innovation-and-Growth